Purple Biotech Ltd. logo

Purple Biotech Ltd. (PPBT)

Market Closed
15 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM)
$
1. 23
0
0%
Pre Market
$
1. 40
+0.17 +13.8211%
187.79K Market Cap
- P/E Ratio
- Div Yield
40,533 Volume
-0.92 Eps
$ 1.23
Previous Close
Analysts:
Add Transaction
Day Range
1.23 1.35
Year Range
1.16 14.1
Want to track PPBT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Purple Biotech Ltd. (PPBT) Statistics

Valuation metrics

Market Cap 187.79K
Enterprise value 5.48M
Trailing P/E (ttm) -0.01
Forward P/E -3.07
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 0.58
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.93

Overview

Shares outstanding 1.86B
Float 1.85B
Shares short 10.48K
% Held by insiders 0.07%
% Held by institutions 0.11%
Average volume (10 days) 26.8K
Average volume (90 days) 27.99K

Price summary

52-Week low 1.16
52-Week high 14.1
Beta -0.57
50-Day moving average 1.62
200-Day moving average 3.31

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 2 Mar 2026

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin -
Operating margin -

Operational effectiveness

Return on assets -1.73%
Return on equity -1.52%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -59K
EBITDA -6.97M
Net income to common (ttm) -26.39M
Diluted EPS (ttm) -2.26
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) 9.57M
Total cash per share (mrq) 0.56
Total debt (mrq) 244K
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 3.72%
Book value per share (mrq) 1.13

Cash Flow

Cash flow statement -5.66M
Levered free cash flow (LFCF) -54K